Skip to main content

Table 1 Population and cancer characteristics by pre-diagnostic colonoscopy among colorectal cancer patients registered in 2003–2013, South Australia (n = 12,906)

From: Pre-diagnostic colonoscopies reduce cancer mortality - results from linked population-based data in South Australia

 

No colonoscopy n = 8194

Colonoscopy n = 4712

Total n = 12,906

P value

Mean age (SD) at diagnosis (years)

69.4 (13.5)

71.5 (12.0)

70.2 (13.0)

< 0.001

Age at diagnosis (years)

   

< 0.001**

  < 60

1843 (22.5%)

764 (16.2%)

2607 (20.0%)

 

 60–69

2025 (24.7%)

1067 (22.7%)

3092 (24.0%)

 

 70–79

2191 (26.8%)

1554 (33.0%)

3745 (29.0%)

 

  > 80

2129 (26.0%)

1326 (28.2%)

3455 (26.8%)

 

Sex

   

0.043*

 Male

4365 (54.7%)

2447 (52.8%)

6812 (54.0%)

 

 Female

3621 (45.3%)

2188 (47.1%)

5809 (46.0%)

 

Country of birth

   

< 0.001*

 Australia & NZ

5486 (68.9%)

3206 (70.2%)

8692 (69.4%)

 

 Europe

1931 (24.3%)

1153 (25.3%)

3084 (24.6%)

 

 North Africa/Middle East

18 (0.2%)

16 (0.4%)

34 (0.3%)

 

 Asia & Pacific Islands

114 (1.5%)

52 (1.2%)

166 (1.4%)

 

 Americas

31 (0.4%)

8 (0.2%)

39 (0.3%)

 

 Africa (other)

370 (4.7%)

130 (2.9%)

500 (4.0%)

 

Indigenous

   

0.100*

 No

7596 (99.8%)

4476 (99.6%)

12,072 (99.7%)

 

 Yes

19 (0.3%)

19 (0.4%)

38 (0.3%)

 

Remoteness

   

< 0.001**

 Major city

6022 (73.5%)

3174 (67.4%)

9196 (71.3%)

 

 Inner regional

893 (10.9%)

508 (10.8%)

1401 (10.9%)

 

 Outer regional and remote

1278 (15.6%)

1029 (21.8%)

2307 (17.9%)

 

SES disadvantage quintile

   

< 0.001**

 1st (most disadvantage)

1884 (23.0%)

1327 (28.2%)

3211 (24.9%)

 

 2nd

1813 (22.1%)

1058 (22.5%)

2871 (22.3%)

 

 3rd

1545 (18.9)

936 (19.9%)

2481 (19.3%)

 

 4th

1615 (19.7%)

809 (17.2%)

2424 (18.8%)

 

 5th (least disadvantage)

1332 (16.3%)

572 (12.2%)

1904 (14.8%)

 

Local Health Network

   

< 0.001*

 Country Health SA

2424 (29.6%)

1689 (35.9%)

4113 (31.9%)

 

 Central Adelaide

2507 (30.6%)

1269 (26.9%)

3776 (29.3%)

 

 Northern Adelaide

1628 (19.9%)

872 (18.5%)

2500 (19.4%)

 

 Southern Adelaide

1634 (19.9%)

880 (18.7%)

2514 (19.5%)

 

Median (IQR) of years survived on Dec 31st 2013

2.7 (0.9–5.5)

3.0 (1.1–6.3)

2.8 (1.0–5.7)

< 0.001

Cancer staging (max spread)

   

< 0.001**

 Local

2001 (42.9%)

1479 (49.8%)

3480 (45.6%)

 

 Regional

1556 (33.4%)

897 (30.2%)

2453 (32.1%)

 

 Distant

1108 (23.8%)

595 (20.0%)

1703 (22.3%)

 

% cancer-specific survival by time from diagnosis

   

< 0.001***

 At 1 year

84.5%

86.8%

85.5%

 

 At 3 year

71.0%

74.6%

72.3%

 

 At 5 year

64.6%

69.4%

66.0%

 
  1. *p from Fisher’s exact or Chi-square test; **p from Mann-Whitney U test; ***p from log-rank test for equality of survivor functions; note - cell totals < overall totals due to missing records